Which AMPA receptor configurations can be considered for a screening project?

The configuration is selected around the study question and may consider GluA1-GluA4 subunit composition, homomeric or heteromeric assembly, flip/flop variants, GluA2 Q/R editing, and relevant auxiliary proteins. Final construct availability and suitability are confirmed during project design.

Can the service distinguish agonists, antagonists, PAMs, and NAMs?

Yes. Addition order, agonist challenge concentration, reference controls, and concentration-response design can be configured to separate direct activation from inhibition or positive and negative modulation. Orthogonal testing is used when the primary readout alone cannot resolve mechanism.

When is electrophysiology recommended?

Electrophysiology is valuable when direct measurement of channel current, gating kinetics, desensitization, deactivation, current-voltage behavior, or detailed potency and efficacy is needed. It can be used as the primary method for focused studies or as a confirmation tier after a scalable cell-based screen.

How are false positives from fluorescence-based assays addressed?

Potential artifacts can be investigated with parental-cell controls, compound-only signal checks, cell-health measurements, repeat testing, an alternative functional readout, or electrophysiology. The exact counter-screen set is matched to the chemistry and primary assay.

Can auxiliary subunits be included in AMPAR screening?

Auxiliary proteins can be considered when they are central to the target biology or desired selectivity. Because they can alter trafficking, gating, and pharmacology, paired comparisons with receptor-only or alternative auxiliary-subunit contexts may be informative.

What information is needed to scope a project?

Helpful inputs include the biological hypothesis, preferred receptor context, compound number and format, expected mode of action, concentration range, desired readouts, available reference compounds, selectivity questions, and the decision the data must support.

What does the final data package include?

The agreed package can include the study conditions, quality-control summary, raw and processed results, compound-level tables, concentration-response analysis, representative traces or plate outputs when applicable, interpretation, and suggested follow-up studies.

Home / Services / Basic Neuroscience related Assays / Ion Channel Screening / Ligand-gated Channel Screening / AMPAR Screening

AMPA Receptor (AMPAR) Screening Service

Creative Biolabs provides customizable AMPA receptor screening for programs seeking agonists, antagonists, positive or negative allosteric modulators, subtype-aware pharmacology, or confirmation of AMPAR-mediated activity. Project support can combine assay strategy, recombinant receptor configuration, functional cell-based screening, electrophysiological characterization, orthogonal counter-screens, quantitative analysis, and collaborative interpretation.

Study design is aligned to the intended receptor subunits, splice or editing state, auxiliary proteins, compound mode of action, throughput requirement, and decision criteria.

Discuss Your AMPAR Program

Why AMPAR Pharmacology Requires Purpose-Built Assays

AMPA receptors are tetrameric ionotropic glutamate receptors assembled from GluA1-GluA4 subunits. Subunit composition, flip/flop splicing, GluA2 Q/R editing, and association with auxiliary proteins such as TARPs or cornichons can alter channel kinetics, ion permeability, trafficking, and compound pharmacology. A result generated in one receptor context may therefore require confirmation in another context that better reflects the program's biological question.

Functional screens must also distinguish direct agonism, competitive or noncompetitive inhibition, positive or negative allosteric modulation, and nonspecific effects on membrane integrity or fluorescence. A tiered plan links scalable primary readouts to mechanistically informative electrophysiology and relevant counter-screens. For programs spanning additional receptor families, our ligand-gated channel screening services and broader ion channel screening services provide complementary assay options.

Study Variables to Define

GluA subunit composition
Flip/flop and Q/R state
Auxiliary subunit context
Agonist and challenge paradigm
Primary and orthogonal readouts

AMPAR Screening Capabilities

The assay cascade can be configured around discovery stage, compound number, expected mechanism, and the receptor biology that matters to the program.

Receptor Configuration

Selection of homomeric or heteromeric GluA receptor formats and, where relevant, splice, editing, or auxiliary-subunit context for the experimental question.

Functional Primary Screening

Cell-based membrane-potential or calcium-flux formats may be used when compatible with the selected receptor construct and screening objective. Projects requiring complementary optical functional readouts can also be aligned with our calcium assay service.

Electrophysiology

Patch-clamp studies can quantify evoked current, potency, efficacy, desensitization, deactivation, use dependence, and concentration-response behavior.

Counter-Screening

Orthogonal checks can address assay interference, cell health, parental-cell activity, and selectivity against related glutamate receptor contexts.

Modes of Action

Agonist activity
Antagonist activity
Positive allosteric modulation
Negative allosteric modulation

Quantitative Endpoints

Endpoint selection may include peak or steady-state response, concentration-response parameters, percent potentiation or inhibition, kinetic constants, current-voltage behavior, and reproducibility metrics appropriate to the assay.

Build a Screening Cascade

Selecting an AMPAR Assay Format

The most informative AMPA receptor assay depends on throughput, receptor configuration, expected mode of action, and the level of mechanistic resolution required. Rather than relying on a single readout, projects can combine scalable screening with orthogonal confirmation.

Membrane-Potential Assays

Voltage-sensitive fluorescence can support higher-throughput functional detection of AMPAR-mediated depolarization and is useful for primary screening, concentration-response studies, and receptor-context counter-screens.

Explore ion channel screening technologies

Calcium-Flux Readouts

Calcium-flux formats can provide an orthogonal functional endpoint when a calcium-permeable AMPAR configuration is scientifically appropriate, helping confirm activity detected in an initial optical screen.

View calcium assay capabilities

Electrophysiological Confirmation

Direct current recording is suited to focused confirmation and deeper characterization of potency, efficacy, desensitization, deactivation, current-voltage behavior, and use-dependent effects.

See integrated ion channel screening

Receptor Context & Experimental Design

AMPAR pharmacology can shift with GluA composition, splice state, RNA editing, and auxiliary proteins. Defining these variables early helps prevent a screening result from being overgeneralized across biologically different receptor populations.

When a project includes other ionotropic glutamate receptors, the AMPAR plan can be coordinated with broader ligand-gated channel screening to support receptor-family selectivity questions.

Subunit Composition

Choose GluA1-GluA4 homomeric or heteromeric configurations that match the biological hypothesis and intended pharmacology.

Flip / Flop & Q/R State

Account for splice and editing states that can influence kinetics, calcium permeability, and sensitivity to AMPAR modulators.

Auxiliary Proteins

Include TARPs, cornichons, or other auxiliary subunits when receptor trafficking, gating, or auxiliary-subunit selectivity is central to the program.

Stimulation Paradigm

Set agonist concentration, pre-incubation, compound addition sequence, repeated stimulation, and timing windows around the expected mechanism.

Mechanism Confirmation & Counter-Screening

A functional signal is most useful when it can be separated from optical interference, general cell stress, receptor-independent activity, and pharmacology that changes across receptor contexts.

Receptor-Dependent Activity

Compare AMPAR-expressing cells with parental or receptor-only controls to identify signals that do not require the intended receptor complex.

Orthogonal Functional Confirmation

Retest prioritized compounds with a second functional modality or electrophysiology when the primary assay cannot independently establish mechanism.

Cell Health & Assay Interference

Use viability, compound-only signal, and repeat-testing controls to distinguish receptor pharmacology from nonspecific effects. Related cellular safety questions can be supported by neurotoxicity screening.

Selectivity Across Contexts

Profile prioritized compounds across GluA configurations, auxiliary-subunit backgrounds, or related receptor families to define where activity is maintained or lost.

AMPAR Screening Across Discovery Stages

The same receptor target can require different assay depth as a program moves from feasibility to hit confirmation and lead profiling. Study scope can be matched to the decision required at each stage.

Assay Feasibility

Establish receptor expression, agonist response, reference pharmacology, signal window, solvent tolerance, and repeatability before compound testing.

Primary Hit Evaluation

Test compound sets with defined controls and response thresholds, then prioritize reproducible activity for concentration-response confirmation.

Lead Profiling

Compare potency, efficacy, kinetic behavior, receptor-context dependence, and selectivity to differentiate closely ranked candidates.

Mechanistic Follow-Up

Resolve PAM, NAM, agonist, antagonist, or context-specific effects using orthogonal functional assays, electrophysiology, and targeted counter-screens.

Why Work with Neurost

Biology-Led Configuration

Receptor composition and assay mode are selected from the scientific question rather than treated as interchangeable.

Tiered Evidence

Scalable functional screening can be connected to electrophysiology and counter-screens for clearer mechanism decisions.

Flexible Collaboration

Projects can range from feasibility and assay development to focused profiling or broader compound screening.

Frequently Asked Questions

Request a Quote

Fill out the form below, and our expert team will contact you to design your custom project and accelerate breakthrough innovations.

AMPA Receptor (AMPAR) Screening Service